Abstract
In this chapter, we will report on the application of folate-based SERS active nanovectors to single cell screening for cancer diagnostics. Owing to the overexpression of folate receptor on cancer cells, their selective targeting with the SERS-nanovector can be achieved. A single cell screening procedure based on Raman microimaging can be used to discriminate normal and cancer cells and the level of folate receptor expression can even be inferred by SERS measurements over statistically relevant cell populations. Therapeutic features of the nanovectors can be implemented by substituting folate molecule with toxic antifolate drugs. As the characterization of folate/antifolate nanovectors was discussed in Chap. 3, here we will mainly focus on the biophysical results of the experiment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ando J, Fujita K et al (2011) Dynamic SERS imaging of cellular transport pathways with endocytosed gold nanoparticles. Nano Lett 11(12):5344–5348
Backman V, Wallace MB et al (2000) Detection of preinvasive cancer cells. Nature 406(6791):35–36
Barlogie B, Raber MN et al (1983) Flow cytometry in clinical cancer research. Cancer Res 43(9):3982–3997
Bazak R, Houri M et al (2015) Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol 141(5):769–784
Bailey LB, Gregory JF et al (1999) Folate metabolism and requirements. J Nutr 129(4):779–782
Boca-Farcau S, Potara M et al (2013) Folic acid-conjugated, SERS-labeled silver nanotriangles for multimodal detection and targeted photothermal treatment on human ovarian cancer cells. Mol Pharm 11(2):391–399
Boecking A, Stockhausen J et al (2004) Towards a single cell cancer diagnosis. Multimodal and monocellular measurements of markers and morphology (5M). Cell Oncol 26(1–2):73–80
Cao D-L, Ye D-W et al (2011) A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. Prostate 71(7):700–710
Chen C, Ke J et al (2013) Structural basis for molecular recognition of folic acid by folate receptors. Nature 500(7463):486–489
Chinen AB, Guan CM et al (2015) Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence. Chem Rev 115(19):10530–10574
Cross SE, Jin Y-S et al (2007) Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol 2(12):780–783
Desmoulin SK, Hou Z et al (2012) The human proton-coupled folate transporter: biology and therapeutic applications to cancer. Cancer Biol Ther 13(14):1355–1373
Domenici F, Bizzarri AR et al (2011) SERS-based nanobiosensing for ultrasensitive detection of the p53 tumor suppressor. Int J Nanomed 6:2033–2042
Domenici F, Bizzarri AR et al (2012) Surface-enhanced Raman scattering detection of wild-type and mutant p53 proteins at very low concentration in human serum. Anal Biochem 421(1):9–15
Dreaden EC, Alkilany AM et al (2012) The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 41(7):2740–2779
Ehrenberg MS, Friedman AE et al (2009) The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30(4):603–610
Fan K, Cao C et al (2012) Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat Nanotechnol 7(7):459–464
Farber S, Diamond LK et al (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 238(23):787–793
Fasolato C, Giantulli S et al (2016) Folate-based single cell screening using surface enhanced Raman microimaging. Nanoscale 8(39):17304–17313
Fasolato C, Giantulli S et al (2018) Antifolate functionalized nanovectors: SERS investigation motivates effective theranostics (in preparation)
Feng D, Song Y et al (2013) Distinguishing folate-receptor-positive cells from folate-receptor-negative cells using a fluorescence off-on nanoprobe. Anal Chem 85(13):6530–6535
Fratoddi I, Venditti I et al (2015) How toxic are gold nanoparticles? the state-of theart. Nano Res 8(6):1771–1799
Fujiwara R, Takenaka S et al (2014) Expression of human solute carrier family transporters in skin: possible contributor to drug-induced skin disorders. Sci Rep 4:5251
Ghosh P, Han G et al (2008) Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60(11):1307–1315
Ghosh SK, Pal T (2007) Interparticle coupling effect on the surface plasmon resonance of gold nanoparticles: from theory to applications. Chem Rev 107(11):4797–4862
Harisinghani MG, Barentsz J et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25):2491–2499
Hattori Y, Maitani Y (2005) Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther 12(10):796–809
Huang X, Jain PK et al (2008) Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 23(3):217–228
Joshi HC, Vangapandu SN et al (2013) Conjugates of noscapine and folic acid and their use in treating cancer. US Patent 8,426,398
Kah JCY, Kho KW et al (2007) Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. Int J Nanomed 2(4):785
Kang MJ, Park SH et al (2013) Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation. Int J Nanomed 8:1155
Kelemen LE (2006) The role of folate receptor a in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer 119(2):243–250
Kneipp J, Kneipp H et al (2010) Novel optical nanosensors for probing and imaging live cells. Nanomed Nanotechnol Biol Med 6(2):214–226
Krinsley DH, Pye K et al (2005) Backscattered scanning electron microscopy and image analysis of sediments and sedimentary rocks. Cambridge University Press, Cambridge
Krüger J, Singh K et al (2002) Development of a microfluidic device for fluorescence activated cell sorting. J Micromech Microeng 12(4):486
Li Y, Heo J et al (2015) Organelle specific imaging in live cells and immunolabeling using resonance Raman probe. Biomaterials 53:25–31
Lu W, Singh AK et al (2010) Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy. J Am Chem Soc 132(51):18103–18114
Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71(1):121–138
Mansoori GA, Brandenburg KS et al (2010) A comparative study of two folateconjugated gold nanoparticles for cancer nanotechnology applications. Cancers 2(4):1911–1928
Mirkin CA, Meade TJ et al (2015) Nanotechnology-based precision tools for the detection and treatment of cancer. Springer, Cham
Mitsunaga M, Ogawa M et al (2011) Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 17(12):1685–1691
Pallaoro A, Hoonejani MR et al (2015) Rapid identification by surface-enhanced Raman spectroscopy of cancer cells at low concentrations flowing in a microfluidic channel. ACS Nano 9(4):4328–4336
Parker N, Turk MJ et al (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338(2):284–293
Salvati A, Pitek AS et al (2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8(2):137–143
Samadian H, Hosseini-Nami S et al (2016) Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. J Cancer Res Clin Oncol 142(11):1–13
Singh R, Kesharwani P et al (2015) Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity. Drug Dev Ind Pharm 41(11):1888–1901
Smith RA, Manassaram-Baptiste D et al (2015) Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA: Cancer J Clin 65(1):30–54
Vo-Dinh T, Wang H-N et al (2010) Plasmonic nanoprobes for SERS biosensing and bioimaging. J Biophotonics 3(1–2):89–102
Weitman SD, Lark RH et al (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52(12):3396–3401
Werner ME, Karve S et al (2011) Folate-targeted nanoparticle delivery of chemo-and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials 32(33):8548–8554
Weddell JC, Imoukhuede PI (2014) Quantitative characterization of cellular membrane-receptor heterogeneity through statistical and computational modeling. PloS one 9(5):e97271
Wibowo AS, Singh M et al (2013) Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition. Proc Natl Acad Sci 110(38):15180–15188
Marietta W, Gunning W et al (1999) Expression of folate receptor type a in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomark Prev 8(9):775–782
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fasolato, C. (2018). SERS-Active Nanovectors for Single-Cell Cancer Screening and Theranostics. In: Surface Enhanced Raman Spectroscopy for Biophysical Applications. Springer Theses. Springer, Cham. https://doi.org/10.1007/978-3-030-03556-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-03556-3_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03555-6
Online ISBN: 978-3-030-03556-3
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)